https://www.selleckchem.com/pr....oducts/emd638683.htm
Unfractionated heparin (UFH) therapy is monitored by using the anti-Xa activity, or the aPTT, which remains the most widely used assay. One of the main advantages of anti-Xa relies on its hypothesized standardization, with a unique therapeutic range (0.30-0.70 IU/mL) for all reagents, whereas aPTT is influenced by numerous preanalytical and analytical parameters not related to the anticoagulant activity of UFH. The aim of this study was to compare the anti-Xa-correlated aPTT therapeutic ranges calculated using different combinations o
Like
Comment
Share
